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"A good traveler has no fixed plans 





Background: Chronic pain beyond three months is a global public health problem. Every 
third adult suffers from a chronic pain condition, resulting in a socioeconomic burden that 
corresponds to 3-10% of gross domestic product in western economies. This burden can be 
largely attributed to absenteeism-related productivity loss where a few highly impaired 
individuals are the most resource-intensive. Simultaneously, a detailed overview of sickness 
absence (SA) associated with chronic pain is complicated by incongruent classification due to 
conflicting perspectives on the condition as either a symptom or a disease in its own right.  
Aim: Based on a well-defined chronic pain population in the Swedish specialist healthcare, 
this thesis primarily aims to provide a SA overview, to explore the possibility of SA 
prevention, and to evaluate interdisciplinary treatment (IDT) as a SA intervention. A 
secondary objective was to assess the psychometric properties of three questionnaires that 
measure the core domains of the chronic pain experience. 
Methods: The aims were addressed in three register-based studies using microdata from five 
Swedish national registers. Study I used sequence analysis to describe SA in 44,241 patients 
over a 7-year period and subsequently developed a machine learning-based model to predict 
chronic pain-related SA in the final two years. Study II emulated a target trial to compare the 
total SA duration over a 5-year period for 25,613 patients that were either included in an IDT 
program or in other/no interventions. Study III analyzed the properties of the Short Form-36 
Health Survey (SF-36), the EuroQol 5-Dimensions instrument (EQ-5D), and the Hospital 
Anxiety and Depression Scale (HADS) within the item response theory-framework. 
Results: SA increased from 17% to 48% over the five years before specialist healthcare entry 
to then decrease to 38% over the final two years. With information on eight predictors, it was 
possible to discriminate between patients that would have low or high SA in the coming two 
years with 80% accuracy. SA trends were similar for patients in IDT programs and other/no 
interventions, albeit the IDT patients had 67 (95% CI: 48, 87) more SA days over the 
complete 5-year period. Finally, the psychometric evaluation revealed that SF-36 adequately 
captured physical and mental health, while HADS was suitable as a measure of overall 
emotional distress, and EQ-5D had insufficient precision for any meaningful application. 
Conclusion: Our findings are most useful to guide policy and research. SA in the studied 
patients remained high over the entire observation period. Decision support tools could prove 
valuable in identifying patients at risk of high SA earlier in the healthcare chain in order to 
direct preventative measures. We found no support for IDT decreasing SA more than 
other/no interventions, but it is possible that this was a consequence of our methodology. 
Further studies of the IDT effects are needed, but uncontrolled designs that attribute SA 
change over time to IDT are inappropriate for this purpose, as the SA peak observed around 
specialist healthcare entry is likely to be driven by the referral procedure. Finally, SF-36 and 
HADS are psychometrically sound measures of the chronic pain experience core domains.  
PREFACE 
This doctoral process was like wandering in an unfamiliar landscape. It involved unexpected 
struggles but was also greatly rewarding, and the destination from the onset was unknown. 
What began as an inquiry into the field of pain became increasingly centered on research 
methodology. Misalignment between expert opinion and evidence triggered the question: 
How certain can we be of our knowledge? 
In chronic pain rehabilitation, experts take the superiority of interdisciplinary treatment (IDT) 
over less comprehensive interventions for granted, and conceptually, it is difficult to 
understand why this would not be the case. It is intuitive that IDT would be more effective: 
based on holistic biopsychosocial theory, it organizes transdisciplinary resources in a 
coordinated attack on the different facets of chronic pain. How could a treatment that adapts a 
multiplicity of other treatments to the problem at hand not be the best solution? Theory does 
not always correspond to practice, however, and despite an ever-increasing body of research, 
the scientific literature is equivocal for many of the outcomes for IDT. Perhaps this is a 
consequence of crude methodology combined with the inherent complexity of the field of 
study. On the other hand, it is no secret that healthcare resources are limited and that 
important theoretical components may be lost in economically feasible practice. The question 
as to whether IDT is an effective treatment strategy thereby remains.  
This thesis could not provide a definite answer to this question, but instead raised a larger 
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ATC Anatomical Therapeutic Chemical Classification System 
CI Confidence interval 
EQ-5D EuroQol 5-Dimensions 
HADS Hospital Anxiety and Depression Scale 
HRQoL Health-related Quality of Life 
IASP International Association for the Study of Pain 
ICD International Classification of Diseases 
IDT Interdisciplinary treatment 
IRT Item response theory 
LISA Longitudinal Integration Database for Health Insurance and 
Labour Market Studies 
MiDAS Micro Data for Analysis of the Social Insurance Register 
NPR National Patient Register 
PDR Prescribed Drug Register 
RMSEA Root mean square error of approximation 
SA Sickness absence including both sick leave and disbility 
pension 
SEK Swedish crowns 
SF-36 Short Form-36 Health Survey 
SQRP Swedish Quality Registry for Pain Rehabilitation 
SRMSR Standardized root mean square residual 








1.1 CHRONIC PAIN 
Classification 
Pain needs no presentation, yet it is elusive. The International Association for the Study of 
Pain (IASP) defines pain as:147  
“An unpleasant sensory and emotional experience associated with, or resembling that 
associated with, actual or potential tissue damage.”  
Pain is thereby a personal experience that extends beyond a physical sensation to 
encompass other domains of life. When pain persists over a longer period of time, it can 
transform from an essential survival mechanism into the harmful state of chronic pain.32  
Chronic pain is a controversial condition. More than half a century has passed since its 
maladaptive destructiveness was first acknowledged.13 Yet, the perception that it is merely 
a symptom of another disease persists until today.65 A paradigm shift is taking place 
towards recognizing chronic pain as a disease in its own right, and it was recently added to 
the 11th revision of the World Health Organization’s (WHO) international classification 
system of diseases (ICD-11) under the diagnostic code MG30.128,146,183,197 Consistent with 
the common interpretation of IASP’s earlier definition, chronic pain is defined by WHO 
as:121,197  
“Pain that persists or recurs for longer than 3 months.”  
This new proposal distinguishes between chronic primary pain referring to conditions 
where it is considered a disease in itself and chronic secondary pain where it originates 
from other diseases.127,183 The chronic primary pain definition highlights the central roles of 
emotional distress and functional disability in the condition:  
“Pain in one or more anatomical regions that (1) persists or recurs for longer than 3 
months, (2) is associated with significant emotional distress (eg, anxiety, anger, 
frustration, or depressed mood) and/or significant functional disability (interference 
in activities or daily life and participation in social roles), (3) and the symptoms are 
not better accounted for by another diagnosis.” 
It can be subclassified into: chronic widespread pain, complex regional pain syndrome, 
chronic primary headache or orofacial pain, chronic primary visceral pain, and chronic 
primary musculoskeletal pain.127,183 Chronic secondary pain is classified into chronic 
cancer-related pain, chronic postsurgical or posttraumatic pain, chronic neuropathic pain, 
chronic secondary headache or orofacial pain, chronic secondary visceral pain, or chronic 
secondary musculoskeletal pain.183 This thesis mainly involves chronic primary pain and 




Chronic pain is a major public health problem. Approximately a third of the global general 
population is believed to suffer from a chronic pain condition.32,49,91,106,165 Prevalence varies 
widely with pain definition and is unevenly distributed so that it increases with female sex, 
age, and low socioeconomic status.32,53,106,165 The Global Burden of Disease study has 
monitored time lived with disability due to non-fatal conditions since 1990, and currently 
covers 369 diseases and injuries in 204 countries and territories globally.60 Musculoskeletal 
disorders are consistently identified among the leading causes and constituted 17% of all 
the time lived with non-fatal disability in 2019.63 Low back pain alone accounted for 7% of 
the total burden and has invariably been isolated as the single leading condition since 
1990.63 Other important contributors linked to chronic pain are found among mental and 
neurological disorders, and include migraine, major depression, and anxiety disorders each 
representing 5%, 4%, and 3% of the total burden in 2019, respectively (Figure 1).63 It is 
virtually impossible to estimate the extent of this burden that can be attributed to chronic 
pain specifically, but the condition likely represents a considerable proportion. While most 
people recover quickly from a pain episode, the prognosis rapidly deteriorates with 
persistent pain.8 As many as two-thirds of low back pain patients in the primary healthcare 
reportedly transit from acute to chronic pain, with a majority still having pain after one 
year.85,90 Cost evaluations of different pain conditions also consistently support that a small 
proportion of individuals with the highest disability represent the majority of the total 
burden.74,75,80,106,114  
 
Figure 1. Percent of total time lived with disability per age group for selected non-fatal condition linked 


























































Socioeconomically, chronic pain represents 3–10% of the annual gross domestic product in 
western economies.19,57,139 In Sweden, the annual costs were estimated at 87.5 billion SEK 
in 2003, while annual costs for diagnoses linked to chronic pain were reported at €32 
billion for 2008.70,171 Most investigations support that indirect costs due to productivity loss 
from absenteeism account for the bulk of the total costs.19,70,139,171,187 Conditions associated 
with chronic pain are the principal causes of prolonged sick leave and disability pension, 
with musculoskeletal disorders, mental disorders, and injuries consistently included among 
the leading diagnoses.4,78,109,188 Musculoskeletal and mental disorders associated with 
chronic pain are also the leading causes of sickness absence in Sweden, accounting for 68% 
of public health insurance costs in 2009.173,174 However, despite numerous studies indirectly 
linking chronic pain to an enormous socioeconomic burden in the form of absenteeism, 
research targeting chronic pain specifically is surprisingly scarce. 
 
Etiology 
The human can be conceptualized as an adaptive supersystem made up of nested and 
interdependent subsystems that strive towards sustaining homeostasis (the balance of 
essential survival processes).25,66 All adaptive systems share the critical features of irritability, 
connectivity, and plasticity, meaning that they are dynamic and responsive to perturbation, 
their components interact, and they can phase shift in response to environmental 
alternations.25 When pain disrupts homeostasis, it induces an allostatic stress response (a 
coordinated regulatory defense mechanism) in neural, endocrine, and immune subsystems.25 
Succinctly, this response can be divided into an immediate component that operates via the 
sympathetic-adreno-medullar axis to activate short-term fight-flight-freezing behaviors and a 
slower component that operates via the hypothalamus-pituitary-adrenal axis to mobilize 
resources for long-term defence.25,64 The allostatic response is a resource-intensive process 
that under normal circumstances is followed by recovery.25 Prolonged stress and 
dysregulation (failure to recover) in any of the subsystems or their connectivity ultimately 
disturbs the entire supersystem and introduces a perpetual phase shift.25 With chronic pain, 
the pathophysiology is not fully understood, but the ability to respond and recover from 
perturbations is disturbed and pain modulating systems are dysfunctional.25 Central and, to a 
lesser extent, peripheral sensitization are considered important mechanisms that lead to 
hypersensitivity, hyperalgesia, and allodynia of pain due to increased neural excitability and 
reduced endogenous pain inhibition.105 
The neuromatrix theory of pain postulates that pain is produced by the neuromatrix (a widely 
distributed neural network) in the brain.119,120 The neuromatrix consists of neurons between 
the thalamus, the cortex, and the limbic system, which involves sensory-discriminative, 
affective, and cognitive perception.120 The chronic pain experience is determined by 
neurosignatures (characteristic nerve impulse patterns) that vary with genetic predisposition 
and sensory input.120 In turn, sensory input is influenced by physical stimuli, psychological 
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stress, and social environment.120 The pain experience and its associated behaviors is thus 
dependent on a dynamic interplay between biopsychosocial factors.50 
 
Experience 
Chronic pain can be a debilitating condition that permeates all aspects of life. What begins as 
a pain sensation, may with time result in impairments that cause more suffering than the 
sensation itself. Whereas individual trajectories are highly variable, their central components 
can be conceptualized within the physical, emotional, and social domains (Figure 2). Physical 
disability often interferes with everyday activities such as walking, exercising, household 
chores, and work.18,45,141 Sleep disturbances are also common and may express themselves as 
poor quality, reduced duration, or insomnia.7,99 Emotional distress in the form of anxiety, 
depression, or anger is another fundamental co-morbidity.21,41,88,148 Both emotional distress 
and sleep disturbances have a bidirectional relationship to the pain, meaning that they 
exacerbate each other in a negative feedback loop.6,32,88 Over time, this physical and 
emotional deterioration adversely effects relationships and even increases the risk of 
employment loss and divorce, which may progressively lead to social deprivation due to a 
gradual withdrawal from society.18,32,45,135,141 Negative consequences further extend to 
surrounding family and friends, whom may suffer greatly due to the additional everyday 
burden, strained interactions, and financial stress.45,141 Typical expressions also include 
physical struggle, mental exhaustion, hopelessness, social isolation, and a general perception 
of life being impoverished and confined.182 All these factors combined contribute to 
decreased health-related quality of life (HRQoL), which reportedly can be as poor in 
individuals with chronic pain as in those with terminal cancer.6  
 






















The chronic pain experience is notoriously difficult to measure and considerable resources 
have been invested into isolating its core domains.29,48,95,183,185 This is an ongoing process, 
with domains still overlapping, morphing, and amalgamating; however, three central 
domains that consistently recur across different entities over time are pain severity, 
emotional distress, and physical function.29,48,95,183,185 Unlike characteristics such as weight 
and height, human experiences are unobservable latent traits that are inferred from 
indicators through statistical procedures.151 Self-report questionnaires are the primary 
source of information for evaluating the chronic pain experience in the clinical setting. For 
them to accurately capture a latent trait, it is necessary that they are valid in the population 
and setting where they are applied, which implicates that they are based on solid underlying 
theory and have statistically robust empirical properties.151 Three widely used 
questionnaires in the health sciences are the Short Form-36 Health Survey (SF-36) of 
physical and mental health, EuroQol 5-Dimensions (EQ-5D) of HRQoL, and the Hospital 
Anxiety and Depression Scale (HADS) of emotional distress.20,77,193,198 Although they have 
been recommended specifically for chronic pain, research has simultaneously highlighted the 
need for evaluation of their psychometric properties as support for their validity is insufficient 
in this population.26,30,33,48 
 
Intervention 
IASP classifies pain interventions into four categories according to their complexity:178 
(1) unimodal treatments: single interventions that target specific pain mechanisms. 
(2) multimodal treatments: several concurrently administered interventions from within 
a single discipline that target different pain mechanisms. 
(3) multidisciplinary treatment: several concurrently administered interventions from 
within multiple disciplines that target different pain mechanisms. 
(4) interdisciplinary treatment: several concurrently administered interventions 
involving a multidisciplinary team that collaborates in the assessment and treatment 
of patients based on the biopsychosocial model. 
It is generally recognized that the biopsychosocial perspective is the most appropriate in the 
assessment and treatment of chronic pain.32,58,59 At the highest level of complexity, 
interdisciplinary treatment (IDT) is considered a chronic pain core intervention.58,96 It is 
theoretically grounded in the biopsychosocial model of illness, which postulates that the 
natural course depends on a dynamic interaction between biopsychosocial factors.32,50,59 By 
concurrently directing physical, psychological, and social measures at the different facets of 
pain, intervention components are believed to act both independently and in conjunction 
with each other.58,96 Because the chronic pain experience is person-specific, it is 
recommended that IDT programs are adapted to each patient’s individual need. Common 
modalities include physical therapy, acceptance and commitment therapy, cognitive 
behavioral therapy, occupational therapy, and pharmaceutical treatment.58,96 However, the 
practical implementation of IDT is highly variable due to personalization and local 
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differences in expertise. IDT fulfills the criteria of complex interventions, which are 
notoriously difficult to evaluate due to their comprehensive and flexible composition 
intended to target multifaceted behaviors.36 This provides an explanation for the limited 
evidence in support of IDT, despite its strong theoretical foundation and the numerous 
studies conducted to evaluate its effects.44,160,171,172,186 Whereas research suggests that IDT 
is marginally superior to less comprehensive interventions where the chronic pain 
experience is concerned, evidence for its effects on sickness absence are 
inconclusive.44,160,171,172,186 
In Swedish specialist healthcare, IDT is offered to patients, the majority of whom are 
referred from primary healthcare, by approximately 40 clinics nationwide.153 National 
guidelines imply that intervention is administered in cohesive programs by experienced 
interprofessional teams that collaborate to personalize care.61 In practice, IDT programs 
vary across clinics, but they primarily focus on group-based activities such as cognitive 
behavioral therapy, physical exercise and occupational training, which are concurrently 
administered by a team of physicians, physiotherapists, occupational therapists, and social 
workers.61,153 Programs are typically delivered 2–5 days per week over a 4-12-week period 
and consist of more than 30 hours in total.153 Not everyone who visits a specialist clinic is 
included in an IDT program, however. As a rule, patients are initially evaluated by the team 
and may be assigned to other/no interventions depending on the evaluation’s outcome, their 
own preferences, and other unspecified factors. Indicators that influence assignment to an 
IDT program are sickness absence history, pain interference with everyday activities, 
emotional distress, and confidence in recovery, while age, sex, socioeconomic status, and 
policy are known to affect healthcare in general.2,15,39,61,116,123 
 
1.2 SICKNESS ABSENCE 
Sickness absence (SA), or absence from work due to incapacity, is a multifactorial 
phenomenon that is determined at the structural levels of a society, organization, and 
individual.3,179 Diverse theories in the fields of psychology, sociology, economics, and 
medical science have presented overlapping yet different perspectives that, either directly 
or indirectly, pertain to the underlying causes of SA.5 Individual characteristics that 
influence SA include age, sex, socioeconomic status, and disability, organizational factors 
include satisfaction due to economic, social, and psychological factors, and societal factors 
refer to macroeconomics, labor market conditions, and social norms.3,164  
The Swedish social insurance system has been implemented to provide economic stability in 
case of work incapacity. The typical working age in Sweden is 18 to 65 years with retirement 
possible from the age of 61. All Swedish residents aged 16 to 64 with minimum income 
from employment or unemployment are eligible for social insurance benefits if their ability 
to work is reduced due to disease or illness. Sick leave is possible from age 16 and is 
granted as full or part time of ordinary work hours.132 Spells are generally compensated for 
by the employer the first 14 days, including a qualifying period with no compensation the 
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first day.132 From the 15th day, spells are reimbursed and recorded by the Swedish Social 
Insurance Agency.132 Since 2008, sick leave benefits are restricted to 364 days per 450-day 
period, with exceptions made for serious illness or if a person’s ability to work has been 
reduced due to an occupational injury.132 Disability pension is also granted at either full or 
part time, with a permanent pension option available for individuals aged 30-64 when their 
working capacity is deemed permanently impaired, and a temporary form possible for 
individuals aged 19-29.132  
 
1.3 CONCEPTS OF SCIENCE  
Causality 
Causality is the relationship between cause and effect. In essence, it can be viewed from two 
opposite perspectives of nature as either inherently deterministic or stochastic.136 The former 
represents the deterministic Laplacian view where randomness reflects an imperfect 
understanding of nature’s underlying mechanisms, while the latter corresponds to the 
stochastic view of modern quantum mechanics where determinism reflects simplification to 
facilitate human understanding.136 This thesis adapts a quasi-deterministic view of causality, 
contextualized through counterfactuals that are consolidated with graph theory, structural 
causal models, and stochastic mechanisms.81,101,107,136 In this context, causal inference is an 
intrinsically epistemic concept that requires prior knowledge to interpret data causally. The 
graph theory provides a visual framework for the assumptions of the overall causal structure 
(Figure 3A), the structural models express the relationships mathematically via sets of 
structural equations that represent causal mechanisms, and the stochastic component reflects 
human’s uncertainty about nature.69,136 However, it is the counterfactuals that ultimately 
allow us to differentiate between causation and association. Counterfactuals are hypothetical 
scenarios that contrast potentialities with the purpose to derive information on ontological 
causal relationships.136 They can be conceptualized under the multiverse and are epistemic 
through their limitation to modal knowledge (i.e., metaphysical necessities and possibilities in 
terms of ‘must’, ‘could’, and ‘could not’) under our perceived laws of nature.107,196 Hence, in 
the context of causal inference, counterfactuals are restricted to the possible worlds. 
The ideal randomized experiment represents the best available emulation of the 
counterfactual multiverse. Properly conducted random assignment ascertains that the average 
sample characteristics are probabilistically equivalent across experimental groups, which 
implies that observed and unobserved biases are balanced.161 Under optimal conditions, the 
experimental groups are thus exchangeable and can be conceptualized as mirror images of 
parallel worlds in all but the intervention.81 In ideal randomized experiments, the intention-to-
treat effect of the intervention assignment is identical to the as-treated effect of the 
intervention itself (Figure 3B).81 However, in practice, they differ with the influence of 
systematic attrition, non-adherence, and non-concealment.81 Imperfect randomized 
experiments are subject to the same type of biases as observational studies and require 
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situation-specific evaluation to determine whether the intention-to-treat or as-treated principle 
is the most appropriate.84,115 The causal structure of as-treated effects in randomized 
experiments corresponds to that of the observational design and is thereby susceptible to 
confounding (Figure 3B). Likewise, both the intention-to-treat and the as-treated principles in 
experiments with differential attrition that are restricted to available participants can induce 
bias via non-causal pathways (Figure 3C). In light of the discrepancy between theory and 
practice of the randomized experiment, it has been argued that the observational design can 
be a better choice in pragmatic evaluation of clinical interventions.71   
 
Figure 3. Directed acyclic graphs (DAG) of causal structures. (A) DAG terminology and rules. The 
pathways Exposure  Outcome and Exposure  Mediator  Outcome represent direct and indirect 
causal effects, respectively. The pathways Exposure  Confounder  Outcome and Exposure  
Collider  Outcome represent non-causal pathways via a common cause and a common effect, 
respectively. Unconditioned pathways via mediators and confounders are open, while pathways via 
colliders are closed until conditioned on (denoted by rectangle). Independent represents a variable 
with no relationships to other variables. (B) Ideal randomized experiment with concealed assignment, 
no attrition, and perfect compliance. The intention-to-treat effect of the assignment Random 
assignment  Intervention  Outcome is identical to the as-treated effect of the intervention itself 
Intervention  Outcome and there are no non-causal pathways from assignment to outcome. (C) 
Unblinded randomized experiment with differential attrition. Both the intention-to-treat and as-treated 
effects are susceptible to bias as the conditioning on non-missing participants opens a non-causal 










(A) Directed acyclic graph terminology
(B) Causal structure of an ideal randomized experiment








Target trial emulation is a recommended strategy for observational studies of causal 
intervention effects.81,83 In this strategy, the protocol of the observational study is adapted so 
that it corresponds to a hypothetical randomized experiment (Table 1).81,83 Target trial 
emulation requires a sufficiently large dataset of adequate quality for meaningful causal 
inferences and is therefore often most suitable for national register studies. Practically, 
individuals that meet the study eligibility criteria are divided into groups based on the 
received intervention and subsequently contrasted with respect to an outcome of interest. To 
ensure that differences in the outcome reflect the causal effect of the intervention, all non-
causal pathways must be closed. This requires strong assumptions on causal relationships 
based on prior knowledge and is managed through any of several methods (i.e., stratification, 
regression adjustment, matching, inverse probability weighting, standardization, or a 
combination of these). Finally, it is critical that the starting point is well-defined so that the 
conditions for all intervention groups under evaluation are the same. 
Table 1. Target trial emulation protocol adapted from Hernan and Robins 2016. 
Component Description Example 
Eligibility criteria Defines the target population that 
the results are generalizable to via 
inclusion and exclusion criteria. 
Adults with non-cancer pain for more than 
90 days that visited a specialist clinic 
between 2009 and 2016. 
Intervention 
strategies 
Describes the intervention and 
control. 
Either an interdisciplinary treatment 
program at a specialist healthcare clinic or 
physical therapy in the primary healthcare.  
Assignment 
procedure 
Defines the causal structure and the 
methods used to close non-causal 
pathways. 
Inverse probability weights are used to 
adjust for baseline confounders identified in 
the scientific literature  
Observation 
period 
Defines the starting point (time 
zero), the maximum duration of the 
follow-up, and other end points 
(e.g., death or loss to follow-up). 
Time zero is the first visit to the clinic and 
patients are followed up to maximum five 
years. 
Outcome Defines the outcome under 
evaluation (e.g., death or sick 
leave). 
Total days of sickness absence over the 
five-year period from time zero. 
Causal contrast Specifies the causal question of 
interest (e.g., intention-to-treat, as-
treated, or per-protocol). 
The intention-to-treat effect of intervention 
assignment. 
Analysis plan Specifies the practical analyses 
used to derive the numeric results. 
Poisson regression with inverse probability 
weights for each patient was used to 








Prediction is the statement of an expected outcome given available information. It is innately 
non-causal, as its focus lies on the correct forecast and the underlying data generating 
mechanisms are of secondary importance. Conceptually, the objective of predictive models is 
to learn the functional relationship that links the features (predictor candidates) to the 
outcome from the data. The learning process requires an algorithm to describe the 
relationship, evaluation criteria to define success, and an optimization method to search for 
the relationship that maximizes success.76 Prediction problems can be divided into either 
regression of quantities or classification of labels.76 As a general rule, predictive performance 
and interpretability increases and decreases with algorithm complexity, respectively; 
however, there is no universally superior algorithm to all problems and performance is 
instead problem-specific.17,76 A useful predictive model is sufficiently complex to capture the 
patterns of interest, while being applicable to datasets not used in the model development. 
This concept is known as the bias-variance trade-off and refers to the balance of the 
systematic and random components in the prediction error, which is needed to optimize 
generalizability (Figure 4A).76 In practice, predictive performance is typically optimized in a 
cross-validation procedure where data is split into parts that, independently from each other, 
are used to learn patterns, evaluate performance, and finally confirm the performance 
evaluation (Figure 4B).76  
 
Latent variables 
Latent variables are unobservable constructs that must be inferred from observed indicators.14  
They can represent human experiences such as depression that are measured by self-report 
questionnaires and societal phenomena such as socioeconomic status that are created from 
register data. The former is defined as a reflective latent variable, which influences its 
indicators, and the latter as a formative latent variable, which is determined by its indicators 
(Figure 5).46,47,54 Their difference carries conceptual and practical implications. A reflective 
latent variable exists independently of its indicators, which, in turn, reflect the latent 
variable’s status, covary because of it, and are unrelated without it. In contrast, a formative 
latent variable does not necessarily represent a real construct, but instead summarizes the 
information of its indicators, which may not covary as they correspond to different causes 
(dimensions) of the construct. The conceptual framework of latent variables is thus critical in 





Figure 4. (A) Conceptual overview of the bias-variance trade-off inspired by Hastie et al., 2017. The 
predictive generalization error consists of three components: two reducible bias and variance 
components that increase and decrease with model complexity, respectively, as more parameters 
enable patterns of higher complexity but are simultaneously estimated with less precision; and an 
irreducible variance component related to the sampling uncertainty. A too simplistic model fails to 
capture the general patterns of interest (underfit), while a too complex model captures sample-specific 
patterns and thus generalizes poorly too new data (overfit). (B) Overview of the cross-validation 
procedure. With data randomly split into three parts, predictive performance is optimized in an iterative 
procedure where the algorithm is trained to learn patterns on the first part and performance is 
evaluated on the second part. Once the final model is selected, its performance is confirmed on the 














































Chronic pain is a globally prevalent condition that represents an enormous socioeconomic 
burden. This burden can largely be attributed to SA-related productivity loss where a few 
highly impaired individuals account for a disproportionate amount of the costs. However, a 
detailed SA overview is complicated by incongruent chronic pain classification due to 
conflicting perspectives on the condition as either a symptom or a disease. Most SA studies 
target associated musculoskeletal disorders rather than chronic pain itself, which is 
problematic, as chronic pain entails other dimensions than the physical, while 
musculoskeletal disorders are not restricted to chronic-pain diagnoses. It is thereby uncertain 
to what extent the results of such studies are specific to chronic pain, which increasingly is 
gaining recognition as its own disease.  
In addition, optimal pain management remains a conundrum, despite the numerous chronic 
pain interventions existing today, with treatment effects known to be both inconsistent and 
small. IDT is a theoretically appealing and internationally recommended core intervention, 
but the current state of evidence is inconclusive where its effects on SA are concerned. This 
can largely be attributed to the combined complexity of chronic pain and IDT, which is 
recognized as a major impediment for high-quality studies. In the absence of properly 
designed and conducted randomized controlled trials, large-scale observational studies are the 
next best alternative for effect evaluations under counterfactual causal inference.  
To meaningfully interpret the SA of the population under study, it is necessary to characterize 
their chronic pain experience. The subjective and heterogeneous nature of the chronic pain 
experience makes it notoriously difficult to capture, but emotional distress and physical 
function are recognized as core domains. These constructs are primarily measured through 
self-report questionnaires, with SF-36, EQ-5D, and HADS recommended specifically for 
individuals with chronic pain. However, their psychometric properties are insufficiently 
evaluated in this population and are in need of further investigation to avoid biased 

















(A) Reflective latent variable (B) Formative latent variable
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2 RESEARCH AIMS 
The primary objectives of this thesis were to provide a sickness absence overview, to explore 
the possibility of sickness absence prevention, and to evaluate the effects of interdisciplinary 
treatment on sickness absence among chronic pain patients in Swedish specialist healthcare. 
Because these questions are contingent on the chronic pain experience, indicators of which 
have been insufficiently evaluated, we also aimed to assess whether its core domains were 
adequately captured by available questionnaires. These objectives were addressed in three 
studies: 
 
 Study I. To describe sickness absence and explore the possibility of predicting future 
high sickness absence at entry into specialist healthcare. 
 
 Study II. To evaluate the effect of interdisciplinary treatment as a sickness absence 
intervention. 
 
 Study III. To assess the psychometric properties of the Short Form-36 Health Survey, 







3.1 DESIGN AND PARTICIPANTS 
This thesis consists of three register-based nationwide observational studies of chronic pain 
patients in the Swedish specialist healthcare system (Table 3). The source population was 
patients in the Swedish Quality Register for Pain Rehabilitation (SQRP), characterized by 
complex clinical presentations and non-response to primary care interventions, and 
corresponding to roughly 0.5‰ of the Swedish population annually. Table 2 details the 
sample characteristics. 
Study I was a cohort study that described SA from five years before to two years after entry 
into specialist care and developed a model for classifying patients based on their SA in the 
final two years. It included 44,241 patients who made their first visit to a clinic during the 
period 2005 to 2016 (82.4% of the source population). Study II emulated a target non-blinded 
randomized controlled trial to estimate the population-average effects of IDT on SA over a 
five-year period. It included 25,613 patients (47.1% of the source population) who had visited 
a specialist clinic between 2009 and 2016. Study III was a cross-sectional psychometric 
evaluation of three self-report questionnaires that capture core domains of the chronic pain 
experience. It included 35,908 adult cancer-free SQRP patients (84.6% of the source 
population) who had visited a specialist clinic between 2009 and 2016. Studies I and II 
included data from the Micro Data for Analysis of the Social Insurance Register, the 
Longitudinal Integration Database for Health Insurance and Labour Market Studies, the 
National Patient Register, and the Swedish Prescribed Drug Register, whereas study III was 




Table 2. Study sample characteristics. 
 Study I Study II Study III 




Patientsa 44,241 (100.0) 13,628 (100.0)  11,985 (100.0) 35,908 (100.0) 
Demographics     
Age (years)b 44 (36, 52) 42 (34, 49) 42 (33, 50) 45 (36, 53) 
Femalea 31,610 (71.4) 10,247 (75.2) 8,018 (66.9) 25,744 (71.7) 
Born in Swedena 34,374 (77.7) 10,861 (79.7) 8,981 (74.9) 27,843 (77.5) 
University/college 
education (>12 years)a 11,881 (26.9) 4,274 (31.4) 3,249 (27.1) 10,048 (28.0) 
Employeda 28,525 (64.5) 10,237 (75.1) 7,529 (62.8) 22,853 (63.6) 
Family’s past 5-year mean 
annual disposable income 
(1000 SEK)b 
174 (129, 233) 194 (148, 250) 179 (131, 235) 189 (141, 247) 
Disability     
Pain duration (years)b 5.7 (2.1, 12.5) 4.6 (1.7, 11.2) 4.8 (1.9, 11.0) 5.4 (1.9, 12.7) 
NRS-10 past week pain 
intensityb 7 (6, 8) 7 (6, 8) 7 (6, 8) 7 (6, 8) 
Most prevalent ICD-10 
diagnosesa     
Fibromyalgia (M79.7) 6,026 (13.6) 2,320 (17.0) 1,668 (13.9) 5,532 (15.4) 
Unspecified pain (R52.9) 3,515 (7.9) 1,121 (8.2) 1,353 (11.3) 3,382 (9.4) 
Myalgia (M79.1) 3,299 (7.5) 1,067 (7.8) 1,101 (9.2) 2,843 (7.9) 
Low-back pain (M54.5) 3,150 (7.1) 1,249 (9.2) 880 (7.3) 2,793 (7.8) 
Cervicobrachial 
syndrome (M53.1) 2,426 (5.5) 861 (6.3) 630 (5.3) 1,986 (5.5) 
HADS emotional distressb 47 (33, 60) 48 (35, 60) 47 (33, 61) 47 (33, 60) 
EQ-5D indexb 0.2 (0.0, 0.6) 0.2 (0.0, 0.6) 0.2 (0.0, 0.6) 0.2 (0.0, 0.6) 
MPI interferenceb 4.6 (3.8, 5.3) 4.5 (3.7, 5.2) 4.5 (3.6, 5.3) 4.5 (3.8, 5.3) 
High confidence in 
recoverya 7,691 (17.4) 3,209 (23.5) 2,063 (17.2) 6,410 (17.9) 
Sickness absencec     
Gross past-year sick leave 
daysb 59 (0, 273) 89 (0, 260) 39 (0, 258) 38 (0, 238) 
Ongoing sick leave at first 
visit to clinica 19,536 (44.2) 6,984 (51.3) 4,906 (40.9) 14,963 (41.7) 
Ongoing permanent 
disability pension at first 
visit to clinica 
7,791 (17.6) 0 (0) 0 (0) 5,195 (14.5) 
a Frequency (percent). b Median (25th, 75th percentile). c due to chronic pain-related ICD-10 
diagnoses: M(00−99), G(43−44, 47, 50−64, 82, 96−97), R(07, 10, 26, 29, 51−52), S(12−13, 22, 32, 




Table 3. Study overview. 
Study Aim Design Registers Observation 
period 
Eligibility criteria Sample 
size 
Statistical analysis 











7 years Inclusion: 
 IDT startyear: 2005-2016, 
 Age at the IDT assessment: 18-64, 
 Pain duration at the IDT assessment: ≥ 90 
days 
Exclusion: 
 A cancer diagnosis in the previous 5 years 
44,241 Unsupervised models: 
 Sequence analysis,  
 Monothetic divisive 
hierarchical clustering 
 
Supervised classification models: 
 Multinomial logistic 
regression, 
 Support vector machine, 
 Gradient boosting machine, 
 Artificial neural network 
II Evaluate the 











5 years Inclusion: 
 IDT start year: 2009-2016, 
 Age at the IDT assessment: 18-60, 
 Pain duration at the IDT assessment: ≥ 90 
days 
Exclusion: 
 A cancer diagnosis in the previous 5 years  
 An IDT assessment the previous 2 years 
 Any permanent disability pension in the 
previous year 
25,613 Reversible Markov multistate model: 
 Non-parametric transition 
model, 
 Flexible parametric transition 
model with inverse probability 
weights 
 Logistic regression exposure 
model for the inverse 
probability weights 
III Evaluate the 
psychometric 
properties of 





SQRP Not relevant Inclusion: 
 IDT start year: 2009-2016, 
 Age at the IDT assessment: ≥ 18, 
 Pain duration at the IDT assessment: ≥ 90 
days 
Exclusion: 
 A cancer diagnosis at the IDT assessment 
35,908 Multidimensional item response 
theory: 
 Logistic graded response 
model 
 Two-parameter logistic model 
LISA, Longitudinal Integration Database for Health Insurance and Labour Market Studies. MiDAS, Micro Data for Analysis of the Social Insurance Register. NPR, National Patient Register. 
PDR, Swedish Prescribed Drug Register. SQRP, Swedish Quality Register for Pain Rehabilitation.   
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3.2 DATA SOURCES 
Swedish National Registers 
The Swedish tradition of register-keeping can be traced back to the 17th century.55 Today, 
there are more than 100 national registers that are available for research purposes. They 
constitute an immense source of microdata that can be linked via personal identification 
numbers held by all Swedish citizens.112 Registers can be categorized into central government 
registers and healthcare quality registers. Government registers are part of the Swedish 
infrastructure and routinely collect data from everyone who meets their eligibility criteria, 
with mandatory participation.55 Their coverage is, therefore, typically very high. In contrast, 
quality registers contain information related to specific health-related conditions and operate 
on a voluntary basis.55 With optional participation for individual health care units and 
informed consent required from individual patients, coverage is not necessarily known and 
could be considerably lower. In this thesis, data were included from five national registers 
and linked per patient via their personal identification number (Figure 6; Table 4).112 
 
Figure 6. Data source overview. Black arrows mark data flow while blue arrows mark the flow of 
personal identification numbers (PIN) for data linkage. 
  
Swedish Quality Registry 
for Pain Rehabilitation
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Database for Health Insurance 
and Labour Market Studies
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Swedish Prescribed 
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SQRP Patients with 
non-cancer 
chronic pain 
referred to a 
Swedish IDT 
specialist clinic 
Pain duration, pain 
intensity, number of pain 
locations, main pain 
location, ICD-10 diagnosis, 
confidence in recovery, 
SF-36, EQ-5D, HADS, 
MPI, clinic’s geographical 
region, date of first visit to 
clinic, IDT selection status 
Up to three 
time points:  




(3) 1 year after 
IDT completion 




MiDAS All individuals 
with one sick 




Spell dates for sick leave 
and disability pension, 
sickness absence extent, 








LISA All individuals ≥ 
16 years 
Sex, age, country of birth, 
family composition, 
education level, disposable 
income 




NPR All individuals 






Inpatient care admission 
and discharge date, 
outpatient specialist care 








PDR All individuals 




Dispense date, ATC-code, 







LISA, Longitudinal Integration Database for Health Insurance and Labour Market Studies. MiDAS, 
Micro Data for Analysis of the Social Insurance Register. NPR, National Patient Register. PDR, 






Swedish Quality Registry for Pain Rehabilitation 
The Swedish Quality Registry for Pain Rehabilitation (SQRP) has consecutively aggregated 
data from specialist interdisciplinary pain management clinics since 1998.131,150 The register 
is managed by Region Skåne via Uppsala Clinical Research Center and is temporally divided 
into several databases, of which SQRP-Access (1998-2009) and SQRP-1 (2007-2017) were 
used here. SQRP targets patients with non-cancer chronic pain who have been referred to any 
of the approximately 40 specialist clinics across Sweden (Figure 7) by primary health care, 
private general practitioners, or hospitals. Specialist healthcare is offered by both university 
hospitals and private healthcare providers. The register contains demographic data, patient-
reported questionnaire data on the pain experience, and data reported by the care providers on 
ICD-10 diagnoses. During the period evaluated in this thesis, SQRP covered roughly 80-95% 
of the specialist clinics across Sweden; however, the participation rate of individual patients 
was not recorded.  
 
Figure 7. Distribution of Swedish SQRP clinics overlaid onto a map with population density per municipality 









Micro Data for Analysis of the Social Insurance Register 
The Micro Data for Analysis of the Social Insurance Register (MiDAS) was developed in 
2004-2005 to permit analyses of individual SA trajectories.132 It was based on the database 
STORE, which covers decisions and reimbursements on the Swedish population from 
1992.132 MiDAS is administered by the Swedish Social Insurance Agency and contains 
information on sick leave spells > 14 days and disability pension spells from all individuals. 
More specifically, it covers spell dates, extent, ICD-10 diagnostic codes, employment status, 
and monetary reimbursement.  
 
Longitudinal Integration Database for Health Insurance and Labour Market 
Studies 
The Longitudinal Integration Database for Health Insurance and Labour Market Studies 
(LISA) is a meta-register established in 1990 that targets all Swedish inhabitants aged ≥ 16 
years.113,163 The register is administered by Statistics Sweden and combines data on an annual 
basis from primary National registers to facilitate analyses of relationships between 
employment and health. LISA contains information on sex, age, country of birth and 
citizenship, highest attained education level, and disposable income. 
 
National Patient Register 
The National Patient Register (NPR) collects data on inpatient healthcare since 1964 and 
outpatient specialist healthcare since 2001.111,125 The inpatient data has complete national 
coverage since 1987, with 99% of somatic and psychiatric inpatient discharges registered.111 
The outpatient data coverage ranges from 70% at the inception to 97% in the recent years.125 
NPR is managed by the National Board of Health and Welfare and contains data on 
healthcare domain, ICD-10 diagnose codes, and date of healthcare. The validity of ICD-10 
diagnoses is reportedly high, with positive predictive values of 85-95% for most diagnoses.111 
 
Swedish Prescribed Drug Register 
The Swedish Prescribed Drug Register (PDR) records data on dispensed prescription drugs 
from Swedish pharmacies since 2005.124,190,194 Prescription drugs are estimated at 84% of 
total drugs dispensed and 77% of total expenditure, with prescription-free drugs and inpatient 
healthcare-administered drugs not covered by the register.194 PDR is managed by the 
National Board of Health and Welfare and contains pharmaceutical descriptors, including 




3.3 SICKNESS ABSENCE 
In this thesis, SA encompassed both sick leave and disability pension. Chronic pain-related 
SA contained the ICD-10 diagnoses for musculoskeletal system diseases (M: 00−99), 
nervous system diseases (G: 43−44, 47, 50−64, 82, 96−97), unclassified pain symptoms (R: 
07, 10, 26, 29, 51−52), injuries and complications (S: 12−13, 22, 32, 42−43, 53; T: 85, 88, 
91−94), and mental disorders (F: 32−33, 41, 43, 45).70 Finally, to distinguish between 
temporary and permanent SA, we further combined the temporary form of disability pension 
for individuals below 30 years with sick leave.3 
 
3.4 STATISTICS 
All analyses were conducted in the open-source software R and Python (libraries are declared 
in supplementary Tables 1S-2S).43,144,145,189 Table 3 details the principal statistical methods 
used.  
In study I, we described SA and developed a prediction model of future chronic pain-related 
SA. Sequence analysis was used to describe SA over a seven-year period and to sort the 
patients according to their chronic pain-related SA patterns during the final two years.56,169 
Briefly, sequence analysis is a non-parametric technique that compares temporal series of 
categorical states between patients and generates a matrix of patient sequence differences.152 
To divide patients into SA subgroups, the difference matrix was analyzed with divisive 
monothetic hierarchical clustering.56 Practically, it is a tree-based method that sequentially 
divides the patients into smaller groups; allowing cluster solutions to be compared with 
respect to statistical quality, robustness, and pertinence.27,152 Predictors of the SA clusters 
were then identified in a machine learning-based modeling procedure with four parallel run 
classification algorithms.28,62,138 The algorithms included multinomial logistic regression, a 
support vector machine, gradient tree boosting, and a multilayer perceptron artificial neural 
network.76 The former is a parametric technique and the latter three can be conceptualized as 
non-parametric techniques given that their parameter number is determined by the data. In 
total, we explored 101 candidate predictors from the domains of sociodemographics, the 
chronic pain experience, SA history, and healthcare. Identified predictors were compared 
between algorithms and the algorithm with the highest predictive performance was selected 
as the final model. Balanced accuracy was used as a primary measure of overall performance, 
while sensitivity and the positive predictive values were included to assess the performance 
of individual classes.10 To maximize generalizability, predictors were chosen in a nested 
cross-validation procedure, during which models were trained and evaluated on independent 
datasets.76 
In study II, a target non-blinded randomized controlled trial was emulated to estimate the 
population-average intention-to-treat effect of IDT on SA. That is, we contrasted all patients 
being offered IDT with all patients being offered other/no interventions (controls). Under a 
set of theory-based causal assumptions, a hypothetical scenario was simulated where patients 
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assigned to an IDT program and to control interventions were equivalent (Figure 8).81 
Markov multistate models were used to estimate the daily probability of SA and the total SA 
duration over a five-year period from the first visit to a SQRP specialist clinic.31,40 Succinctly, 
such models generalize the standard survival approach to account for both recurrent and 
competing events; however, they require that possible states, possible transitions, and 
transition models are selected in advance.37,118,195 Markov models describe stochastic 
processes under the assumption that the next state transition is dependent on the transition 
history through the current state only.118 We included three states: no SA, full or partial sick 
leave, and full or partial disability pension. Bidirectional transitions were possible between 
the former two states and unidirectional transitions were possible from any of the former two 
states to the disability pension state. Transitions were modeled with the non-parametric 
Aalen-Johansen estimator for the unadjusted observed SA and with flexible parametric 
survival models for population-average SA.1,37,67 Concisely, the Aalen-Johansen estimator is 
a generalization of the non-parametric Kaplan-Meier estimator for the hazard of a survival 
process to multiple states, whereas the flexible parametric model of proportional hazards 
captures the shape of the baseline hazard function with restricted cubic splines that are joined 
at knots predefined in number and placement.1,37,67 Restricted cubic splines are piecewise 
third-degree polynomials that are constrained to form smooth functions, which are linear 
beyond the boundary knots.176 We used the Bayesian information criterion to guide the 
number of knots and placed them equally over the quantiles of the event time distribution.176 
The flexible parametric model is advantageous in that it provides a measure of absolute 
effects and easily incorporates time-dependent effects via interaction between covariates and 
splines of time.176 To account for our causal assumptions, the parametric transition models 
were estimated with stabilized inverse probability weights derived from a logistic regression 
exposure model.81 Conceptually, the inverse probability weights are used to construct a 
pseudo-population by re-weighting the patients according to their propensity score of 
intervention assignment, which eliminates the association between the confounders and the 
intervention.81 At their theoretical boundaries, the expected weights are equal for all patients 
with random assignment, while they are infinitely large for the control patients with 
completely deterministic assignment. Finally, stabilized weights use the marginal probability 
of intervention assignment in the numerator to avoid extreme weights due to a low 




Figure 8. Assumed causal structure. Figure reproduced from study II under CC BY 4.0. 
 
In study III, we evaluated the psychometric properties of SF-36, EQ-5D, and HADS. 
Analyses first targeted structural validity, then internal consistency reliability, and finally 
convergent/discriminant validity. Structural validity of recognized theoretical constructs for 
each questionnaire was examined within the item response theory (IRT)-framework.24 
Concisely, IRT models describe the relationship between observed indicators (e.g., the 
questionnaire items) and a stipulated latent trait (e.g., depression).149,151 The two types of IRT 
models used here were the logistic graded response model for ordered multicategory item 
responses and the logistic two-parameter model for dichotomous item responses.159 
Unidimensional IRT models were used when theories motivated a single latent trait and 
corresponding multidimensional extensions otherwise. To identify the empirical 
representations with the best structural properties, several fit indices were compared in a five-
fold cross-validation procedure.76 These included the root mean square error of 
approximation (RMSEA) and the standardized root mean square residual (SRMSR) as 
primary global fit indicators, with estimates ≤ 0.05 considered acceptable for both.117,151 Once 
the most structurally sound models were identified, the internal consistency reliability of the 
latent traits was computed as a summary measure of their precision, with estimates ≥ 0.70 
considered acceptable.180 Finally, convergent and discriminant validity were evaluated via the 






















This project was approved by Uppsala’s Regional Ethical Review Board (DNR 2018/036) 
and conducted in accordance with both the declaration of Helsinki and the guidelines on good 
research practice by the Swedish Research Council. The autonomy of the patients was 
respected as participation in SQRP mandated a written informed consent, which declared 
their legal rights and the possibility of data linkage to other registers. The risk of privacy 
infringements was minimized by encoding personal identification numbers before data 
extraction from register holders, by storing patient information in a secure location, and by 
limiting presented results to aggregate level to prevent indirect identification. Finally, the 
project added no additional burden to the healthcare system as it was strictly based on 







4.1 SICKNESS ABSENCE OVERVIEW (STUDY I) 
Between 17% and 49% of the patients received chronic pain-related SA benefits at any given 
time during the 7-year observation period (Figure 9). Whereas chronic pain-related SA 
peaked around entry into specialist healthcare, SA linked to other diagnoses remained 
relatively constant over the full period. Chronic pain-related SA was unevenly distributed 
between patients so that a fifth received no benefits, another fifth accounted for 56% of the 
net days, and three-fifths of the patients shared the remaining SA days. 
 
Figure 9. The daily sickness absence state distribution from five years before to two years after entry 
into specialist healthcare. Grey area denotes the most likely period in which a patient subsample was 
included in an IDT program. (A) Chronic pain-related sickness absence defined as ICD-10 codes: 
M(00−99), G(43−44, 47, 50−64, 82, 96−97), R(07, 10, 26, 29, 51−52), S(12−13, 22, 32, 42−43, 53), 
T(85, 88, 91−94), and F(32−33, 41, 43, 45). (B) Sickness absence related to non-chronic pain 

































(A) Chronic pain−related sickness absence
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4.2 SICKNESS ABSENCE PREDICTION (STUDY I) 
Patients were divided into three clusters based on their chronic pain-related SA in the two 
years following their first visit to a SQRP clinic (Figure 10). The first cluster contained 
patients with low SA that either received no social insurance benefits or recovered rapidly 
from such benefits (n=25,294). The second cluster was characterized by patients with high 
sick leave that either remained on sick leave until the end or stopped receiving sick leave 
benefits during the second year (n=5,416). The third cluster included patients with any 
amount of permanent disability pension (n=3,723). Finally, patients with permanent disability 
pension registered in the five years before entry into specialist healthcare were excluded from 
the prediction analyses to avoid inflated predictive performance (n=9,893). 
 
Figure 10. Cluster-wise daily distribution of chronic pain-related SA for the two years following the first 
visit to a SQRP clinic. The pie chart illustrates the patient distribution per cluster. Figure adopted from 
study II under CC BY 4.0. 
 
In total, ten predictors of future SA were identified by the four algorithms (Figure 11). 
Information on sick leave history contributed the most to predictive performance and was 
included in the best models by all algorithms. Other consistently identified predictors were 
age and an indicator of a 2008 policy, while a southern Sweden geographical location and 



































































configuration was selected as the final model as it slightly but consistently outperformed the 
other algorithms. On average, it predicted 68% of the patients correctly across the three 
outcome classes compared to 33% by chance (balanced accuracy=0.68). The model was 
useful for predictions of low and high SA (sensitivity≥0.64; positive predictive value≥0.61), 
but not for future disability pensions as its low prevalence contributed to only one in four 
positive predictions being correct (sensitivity=0.70; positive predictive value=0.26). Instead, 
model performance was acceptable when collapsing high sick leave with disability pension 
(balanced accuracy=0.81; F1 score=0.79; sensitivity and specificity≥0.79; positive and 
negative predictive values≥0.70).  
 
Figure 11. Predictors included in the final model configuration by algorithm. Blue and red denotes an 
included and non-included predictor, respectively. Numbers represent the loss in balanced accuracy 
for omitting the predictor.  
 
15.4 11.5 5.5 11.5
10.9 8.6 2.8 8.4
8.3
2.6 1.3 1.9
1.7 5.5 5.8 4.5










































4.3 SICKNESS ABSENCE INTERVENTION (STUDY II) 
Of the 25,613 patients that met the eligibility criteria, 13,628 were IDT patients and 11,985 
were patients assigned to other/no interventions. The intervention groups were similar in most 
measured baseline characteristics, apart from some variations in sex, geographical location, 
and employment status. SA trends were almost indistinguishable between groups from five 
years to one year before entry into specialist healthcare (Figure 13A). Sick leave then 
distinctly increased for IDT patients until the end of the assumed intervention period, rapidly 
decreased in the next year, and stayed slightly elevated over the remaining follow-up time 
compared to controls (Figure 13B). In contrast, disability pension trends were more similar 
between groups, with a steady increase from first visit to the clinic. SA patterns remained 
similar when stratifying on specialist clinic type (Figure 12). Over the five-year period, the 
mean difference in unadjusted and adjusted gross SA amounted to 75 days (95% CI: 58, 92) 
and 67 days (95% CI: 48, 87), respectively. Hence, neither observed nor population-average 
SA estimates supported any clinically meaningful effects in favor of IDT compared to 
other/no interventions.  
 
Figure 12. Unadjusted sickness absence by specialist clinic type. Colored areas display proportion of 
patients with sick leave (orange) and disability pension (red). Black and turquoise edges indicate IDT 































Figure 13. Sickness absence for patients included in an IDT program (solid line) and patients 
assigned to other/no interventions (dotted line). Time zero marks the first visit to the specialist clinic 




















































(C) Adjusted sickness absence
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4.4 PSYCHOMETRIC PROPERTIES OF CHRONIC PAIN EXPERIENCE 
QUESTIONNAIRES (STUDY III) 
Figure 14 illustrates the empirical representations with the best properties under the IRT 
framework for all three questionnaires. SF-36 was most suitable for capturing the two 
independent traits of physical and mental health that were jointly estimated with subscale-
specific residual factors. EQ-5D could be used as a unidimensional measure of HRQoL, 
while HADS best measured overall emotional distress when adjusted for the two residual 
factors of anxiety and depression. All three questionnaires were structurally sound (RMSEA 
≤ 0.048; SRMSR ≤ 0.038) and their convergent/discriminant validity was supported by a 
logical association between the latent traits (Figure 15). However, whereas precision was 
acceptable for SF-36 and HADS (internal consistency reliability ≥ 0.79), it was inadequate 
for EQ-5D under the unidimensional IRT model (internal consistency reliability = 0.60). 
 
Figure 14. The empirical representations of each questionnaire with the best properties for chronic 
pain patients. Latent variables, assumed causal pathways, and questionnaire items are denoted by 
circles, arrows, and rectangles, respectively. PHS and MHS, physical and mental health summaries, 
respectively. PF, physical function. RP, role-physical limitations. BP, bodily pain. GH, general health. 
VT, vitality. SF, social function. RE, role-emotional limitations. MH, mental health. HRQoL, health-
related quality of life. ED, emotional distress. Anx, anxiety. Dep, depression. Figures reproduced from 




Figure 15. Correlation between IRT-based trait scores (bold) and conventionally estimated scores. 
PHS and MHS, physical and mental health summaries, respectively. HRQoL, health-related quality of 
life. ED, emotional distress. PF, physical functioning. RP, role-physical limitations. BP, bodily pain. 
GH, general health. VT, vitality. SF, social functioning. RE, role-emotional limitations. MH, mental 
health. PCS and MCS, physical and mental component summary scores, respectively. VAS, visual 





























5.1 MAIN FINDINGS 
This thesis provided a SA overview, explored the possibility of SA prevention, and evaluated 
IDT as a SA intervention among chronic pain patients in Swedish specialist healthcare. It also 
assessed the psychometric properties of the instruments SF-36, EQ-5D, and HADS as core 
measures of the chronic pain experience.  
Our results revealed a clear increase in SA over the five years before specialist healthcare 
entry, which then reversed and decreased over the next two years. Overall, nearly a fifth of 
the patients received SA benefits at any given time and almost half of them were on SA when 
they entered specialist healthcare. SA was also unevenly distributed so that a fifth of the 
patients accounted for nearly three-fifths of the SA net days. A model was developed with 
eight predictors of future SA that could differentiate between low and high SA at 80% 
accuracy. SA history contributed the most to predictive performance, while a temporal 2008-
policy indicator, age, confidence in recovery, and geographical region were other predictors 
of lesser importance. Compared to unspecified treatments or recommendations, IDT did not 
offer any advantage in terms of SA reduction over a five-year period, under the assumption 
that the two groups were equivalent given our theory-based causal structure. Finally, our 
psychometric evaluation revealed that structurally sound and logically associated 
representations could be identified for all three questionnaires, but that EQ-5D was 
insufficiently precise as a unidimensional measure of HRQoL. 
 
Sickness absence overview 
Chronic pain disorders are recognized as leading contributors of prolonged SA, but SA 
overviews specific to chronic pain are rare due to difficulties in isolating the condition 
directly.4,78,109,188 SQRP allowed us to describe SA in a well-defined clinical population 
with chronic pain impairments ample enough to motivate a specialist healthcare referral. 
Our findings are interesting from several perspectives. First, they provide a precise measure 
of the SA extent, which supports that SA is high among these patients. In the seven years 
surrounding specialist healthcare entry, patient-mean annual net SA ranged between 54 to 
145 days compared to a maximum of 43 days for the general Swedish population over the 
2000-2018 calendar period (Figure 16).175 Second, they highlight the two years before to 
two years after specialist healthcare entry as a critical period for SA prevention and 
evaluation. This implicates that efforts to identify patients at the start of the period could 
prove to be valuable to mitigate the rapid SA increase in the coming two years, while 
intervention evaluations would capture the largest effect over the two years following IDT. 
Third, in agreement with previous reports, they show that SA is also unevenly distributed in 
this clinical population and that distinct SA strata can be isolated.74,75,80,106,114 This 
implicates that large socioeconomic gains are possible by identifying and directing 
intensive intervention at the minority with the most SA.  
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Our findings also carry methodologically important implications. Because chronic pain-
related SA is a strong indicator for IDT, the SA peak observed around specialist healthcare 
entry is likely a consequence of the patient selection procedure in the earlier healthcare 
chain.15,61 The IDT referral indicates that patients are approaching their worse during this 
time and subsequent SA decrease could represent treatment response, natural course, placebo, 
Hawthorne effects, and statistical phenomena such as regression to the mean.51,161 Moreover, 
the sharp SA increase following the first clinic visit likely reflects sick listing for IDT patients 
to enable program participation.72 These two factors combined suggest that uncontrolled 
studies of interventions in specialist healthcare should be avoided as they artificially inflate 
treatment effects. 
 
Figure 16. Sickness absence in the Swedish general population. Lines denote the moving 12-month 
mean for insured individuals aged 16-64. Source: Swedish Social Insurance Agency. 
 
Sickness absence prediction 
Early identification of high-risk patients is an important step in SA prevention. We examined 
whether future SA could be predicted from data known at the time of specialist healthcare 
entry and found that it was possible to discriminate between patients with future low and high 
SA at a meaningful accuracy. However, as interventions in practice are guided by clinical 
expertise, it would be more interesting to compare model predictions to the clinicians’ 
expectations upon meeting the patient in the future. 
In agreement with previous studies, SA history contained the most important information for 
identifying patients with future high sick leave or disability pension.42,92,98,100,156,191 
Performance was specific to chronic pain-related SA, which is consistent with earlier 
reports.42,92 Two other clinically relevant predictors of future SA were age and confidence in 
recovery. In line with previous studies, our results suggested that the former was positively 

















pension.98,102,156,191 Meanwhile, two identified predictors of limited clinical importance were a 
2008-policy indicator and geographical region, which aligned with previous reports of  
municipal and temporal SA differences.103,108,167,191 Earlier SA risk factors that did not 
improve performance were sex, education, employment status, and multimorbidity.98,156,191 
 
Sickness absence intervention 
Despite its strong theoretical foundation and international status as a chronic pain core 
intervention, support for IDT is surprisingly limited.44,97,129,160,186 The latest Cochrane 
evidence summary from 2015 revealed that the odds of return-to-work is the same for 
patients undergoing IDT as for those receiving usual care.97 Other evidence summaries also 
generally agree that the support for IDT as a SA mitigator is equivocal.44,97,160,186 
IDT in specialist healthcare is the most complex chronic pain intervention in Sweden today. 
Within this context, we conducted a pragmatic register-based study of its effects over a five-
year period and found no support for IDT decreasing SA to a higher extent than alternative 
interventions. Our findings were consistent with three of seven peer-reviewed controlled 
studies published in the past decade that compared IDT to usual care over at least one 
year.22,122,137 Two were randomized controlled trials that reported no differences in SA and 
return-to-work and one was a matched-cohort study that reported a slight advantage in SA for 
the controls. In addition, our results mirror the findings of a governmental evaluation in the 
form of a matched-cohort study of IDT in primary healthcare.72,73 Conversely, four 
randomized controlled studies provided some support for IDT being superior to usual 
care.12,23,79,155 Two of these studies reported IDT having up to large effects on SA, while the 
other two reported up to moderate effects on return to work. In summary, the evidence of IDT 
effects on SA remains inconclusive.  
Our choice to use the patients merely assessed and offered other interventions or 
recommendations as controls was criticized in a commentary.154 We agree that it introduces 
susceptibility to bias, as treatment assignment is influenced by clinical expertise and patient 
preference. Nevertheless, the intervention groups were similar in most measured baseline 
variables and our design strived towards further increasing their comparability by adjusting 
for theory-driven confounders identified in the scientific literature. As discussed in our reply, 
the proposed alternative of using the IDT patients as their own controls is not a viable 
solution, as the effects specific to IDT cannot be isolated in such designs.110  
 
Psychometric properties of chronic pain experience questionnaires 
SF-36, EQ-5D, and HADS are questionnaires widely implemented for measuring the 
chronic pain experience, but their properties are not sufficiently evaluated in the chronic 
pain population.26,30,33,48 SQRP presented an excellent opportunity for assessing their 
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construct validity and internal consistency reliability under the psychometric IRT 
framework.  
In agreement with its original theory, SF-36 was a valid and precise measure of two meta-
constructs of physical and mental health.77,193 Other studies typically also support these two 
constructs irrespective of the population investigated.11,52,68,77,184,192,193 However, since the 
inception of SF-36, there is an ongoing debate on whether they should be perceived as 
independent or correlated.77,193 Our results supported the former view, estimated in the form 
of a two-tier model, where all items loaded directly on both meta-constructs. To mitigate 
the known discord between the meta-constructs and domain-specific constructs, all item-
trait loadings were constrained to positive values, but the problem was not completely 
eliminated and further improvements are likely possible.177 Nevertheless, the physical and 
mental health constructs were logically associated both with the domain-specific constructs 
and with the constructs of EQ-5D and HADS. 
Despite its underlying theory as a formative multidimensional scale, our results supported 
that EQ-5D was structurally valid, albeit imprecise, under the psychometric unidimensional 
model.20 This is consistent with previous studies that also evaluated EQ-5D as a 
unidimensional scale in patients with chronic pain and mental illness.93,142,166 However, 
because its theoretical foundation places each of the five items in a different dimension, we 
cannot exclude that the perceived unidimensionality was a consequence of insufficient 
sensitivity in fit evaluation methods.34 It is nevertheless peculiar that the IRT-based HRQoL 
score was so strongly associated with the conventional index, despite their conceptual 
differences. However, this contradiction is of little practical concern as we discourage the 
use of EQ-5D as a unidimensional measure due to its low precision.16  
HADS had the best properties as a measure of overall emotional distress, which 
conceptually closely relates to the anxiety and depression constructs defined in its original 
theory.198 Whereas the bifactor model provided a valid and precise measure of emotional 
distress, HADS structural properties were not acceptable as a measure of anxiety and 
depression, which explains the criticism it has received in the past.35 However, simply 
summarizing the score is not recommended, as the unidimensional HADS model had the 
worse properties of all structural models. Instead, the score should be adjusted for residual 
item dependencies of the anxiety and depression constructs. Our results are consistent with 
an earlier meta-study of mixed populations and largely also with the findings of two other 
studies that shared one chronic pain patient sample.130,133,134 The combined research thereby 






5.2 METHODOLOGICAL CONSIDERATIONS 
 
Main limitations 
It is critical to interpret scientific findings in light of their methodological limitations. 
Predictive studies are influenced by procedural decisions and can become obsolete if their 
underlying circumstances change, while systematic bias is the main threat to the internal 
validity of large-sample observational studies that estimate intervention effects, and 
psychometric evaluations are contingent on the questionnaire’s underlying theory. 
In study I, both the data management and the analyses required several methodological 
compromises. Numerous decisions were taken in the preparation of the SA data. First, the SA 
extent of each spell was treated as uniformly distributed, despite the knowledge that spells 
often decreased, increased, and varied over time. Second, non-permanent disability pension 
was reclassified as sick leave to better distinguish between permanent and non-permanent 
absenteeism, which was suboptimal and may complicate comparison with other studies. 
Finally, we differentiated between SA directly related to the chronic pain spectrum and other 
diagnoses for a more specific overview of its socioeconomic consequences.70 However, a 
minimal but distinct SA increase around specialist healthcare entry indicated that other 
diagnoses were also influenced by the chronic pain condition (Figure 9B). With the SA data 
processed, sequence analysis was chosen because it provides a holistic overview of the SA 
trajectories and detailed insight into individual patient patterns.152 This technique further 
makes no assumptions about the data-generating mechanisms, which aligned well with the 
exploratory approach taken in this study.140 Our modelling procedure also had a direct impact 
on the interpretation of our results. Studies that explore the link between features and an 
outcome ultimately prioritize to either understand their relationship or to predict the outcome 
of individual analysis units.17,162 Under the right circumstances, the former provides an 
accurate description of theoretical associations, but does not necessarily imply predictive 
ability.162 Conversely, the latter excels in prediction at the cost of decreased accuracy and 
interpretability of the associations.162 We took a machine learning-based approach, as our 
primary interest was to examine the extent to which future SA could be predicted at entry into 
specialist healthcare. The model with the highest performance did not provide a parsimonious 
summary of the associations between features and outcome, which instead needed to be 
interpreted indirectly. However, the many collinear features included among the predictor 
candidates, render it unlikely that a strictly regression-based approach would have been more 
informative.17 As in any optimization procedure, there is no guarantee that the optimal model 
is identified unless all possible combinations are tested. Moreover, only a small portion of the 
hyperparameter space could be feasibly searched in the algorithm tuning. However, the 
parallel trial of four complementary algorithms resulted in models that largely confirmed 
each other. Noteworthy is that there generally was a considerable information redundancy 
within the feature domains and whereas the selected features represented those most 
important, other combinations approached a similar performance. 
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In study II, we estimated the population-average treatment effect of IDT assignment on SA 
under the framework of counterfactual causality. Target trial emulation is a strategy used for 
observational data to achieve the design-based inference of a randomized trial.81,86,89,158 
However, in addition to the statistical assumption of no model misspecification and no 
measurement error, causal inference necessitates the three untestable identifiability 
assumptions of consistency, positivity, and exchangeability.81 First, the assumption of 
consistency asserts that observed and potentially factual outcomes are identical under a given 
circumstance, which implies that the intervention is sufficiently well-defined for consistent 
treatment effects. In our study, this assumption was likely violated due to the large 
heterogeneity of both IDT and control interventions across the specialist clinics. Nonetheless, 
we are confident that IDT systematically represented a higher level of engagement with the 
patient, given that it is the most extensive treatment offered. Second, the assumption of 
positivity proclaims that all the patients have a possibility of entering either intervention. Our 
data supported that this assumption was met, since both the distribution of measured baseline 
characteristics and examined covariate pattern frequencies were similar between the 
intervention groups. Third, the assumption of exchangeability affirms that the intervention 
groups are probabilistically equivalent at baseline. In our study, exchangeability was assumed 
conditionally on our causal structure (Figure 8) and subject to possible confounding bias, 
measurement bias, and selection bias.81,104,157 Confounding bias is introduced via causes 
common to the intervention and outcome and is a major concern in observational studies, 
especially here since IDT was assigned in a clinical decision process. To manage this issue, 
we adjusted for important theory-driven confounders through inverse probability weights; 
however, some residual confounding likely remained, which can have biased our estimates in 
an unknown direction. This was possible either via suspected confounders that were 
unavailable to us or via other unknown confounders. Meanwhile, selection bias is introduced 
by conditioning on a common effect of both the intervention and outcome.81 In our study, 
missingness can have influenced the results by opening non-causal pathways through 
conditioning on the patients with complete baseline data (Figure 17).81,82 It would therefore 
have been preferable to manage the missingness rather than simply summarizing it. However, 
because the missingness was in the confounders, it could not simply be adjusted for in the 
inverse probability weights. Moreover, there was a limited selection of suitable auxiliary 
variables needed for multiple imputation, which further would have been rather 
computationally demanding when combined with the bootstrap confidence intervals 
recommended for inverse probability weighted-survival models.9 Finally, measurement error 
cannot be described in terms of one general causal structure. Instead, it takes on several forms 
that are categorized under either non-differential or differential mismeasurement, where the 
errors of the intervention and outcome are independent and dependent, respectively.81 Non-
differential mismeasurement of intervention or outcome typically attenuates the causal effects 
through dilution, but imprecise measurement of confounders can also exacerbate them, since 
it results in them being incompletely partialled out.81,157 In our data, the absence of 
information on SA spells below 15 days, retirement, emigration, and death introduced SA 
misclassification, which implies that the SA difference between intervention groups was 
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underestimated unless the SA misclassification was differential. This is, however, unlikely 
since it was prospectively measured by the external government apparatus. In contrast, 
mismeasurement of the self-report confounders emotional distress, everyday interference, and 
confidence in recovery likely biased the results in an unknown direction. Finally, besides the 
identifiability assumptions, model misspecification was possible though the logistic 
regression of the inverse probability weights, the flexible parametric survival models, and the 
Markov multistate model; model diagnostics were used to mitigate the possibility.181 In 
summary, our results are contingent on several strong assumptions of which at least some 
were likely violated, thereby rendering it uncertain to what extent our estimates are 
reasonable approximations of the causal effect. However, given the magnitude of the negative 
effects found for IDT, considerable bias would be needed to obtain a clinically meaningful 
effect in favor of IDT. 
 
Figure 17. Directed acyclic graph of selection bias due to conditioning on patients with complete 
baseline data. 
 
In study III, we evaluated the empirical properties of SF-36, EQ-5D, and HADS. The 
procedure relied upon indirect quality metrics contingent on the conceptual frameworks of 
the questionnaires, with cross-validation used to confirm the adequacy of the functional item-
trait models.149,151,162.162 Nonetheless, the absence of an observed outcome makes the 
assessment of unsupervised problems complicated, which presented some practical 
difficulties. Most obviously, the conceptual model of EQ-5D as a multidimensional HRQoL 
measure with only one item per dimension prevented us from determining whether it was 
appropriately represented in a reflective model.34 However, the strong relationship between 
the IRT-based reflective score and the traditional EQ-5D index nonetheless suggested that it 
ordered respondents on the HRQoL continuum in a similar manner, as previously reported.143 
In addition, our investigation was restricted to the marginal questionnaire properties, thereby 
assuming a uniform behavior in item responses irrespective of patient characteristics. It is 
possible that patients at the same latent trait status have tendencies to respond differently to 
individual items depending on their characteristics, which could invalidate our results if the 










Generalizability is dependent on eligibility criteria and sampling procedure. Our target 
population was chronic pain patients in Swedish specialist healthcare, while the source 
population was defined by SQRP, which consecutively aggregates patient data on a voluntary 
basis. A selection procedure on multiple levels could thus have decreased the sample 
representativeness relative to the target population.104 First, the coverage of specialist clinics 
in SQRP was incomplete. This sample restriction was likely negligible, as 80-95% of clinics 
were included during the study period and non-participating clinics most probably had a low 
patient flow. Second, patients could decline to participate due to the voluntary consent 
requirement. Because there was no information on the decline rate and participation could be 
driven by patient characteristics, this selection represented the largest risk to generalizability. 
Finally, missing data on our study eligibility criteria potentially contributed to sample 
restriction if it systematically related to patient characteristics, but was likely negligible given 
the relatively small amounts of missingness. In light of these factors, the exact population 
characteristics remain unknown, leaving the possibility that a patient subgroup was not 
included in the study sample. Nevertheless, our results are relevant to adults with 
considerable chronic pain-related everyday impairments and a decreased HRQoL in Sweden. 
The SA trends described in study I will likely remain similar, peaking around entry into 
specialist healthcare, albeit varying in absolute numbers. Likewise, the identified SA 
predictors were congruent with the results of several previous studies and are therefore likely 
to remain important in the future. However, even for the features evaluated here, the model 
composition and performance could differ with changed circumstances, as measurement error 
reduced performance and may have prevented otherwise important features from being 
selected in their current form. With respect to IDT, even when assuming adequate internal 
validity, the effects on SA reported in study II are highly dependent on program content and 
could change with the IDT development. Finally, the questionnaire measurement properties 
evaluated in study III should be generalizable to Swedish speakers forward in time unless the 
population characteristics change drastically. It is uncertain as to what extent they are 
applicable to other languages, but it is reassuring that our results corresponded well to 




This thesis has provided a sickness absence overview, explored the possibilities of sickness 
absence prevention, and evaluated interdisciplinary treatment as a sickness absence 
intervention among chronic pain patients in Swedish specialist healthcare. In addition, it 
presented psychometric information on three common questionnaires of the chronic pain 
experience. 
 Sickness absence was high in the studied patients over the entire observation period. 
Temporally, it peaked around specialist healthcare entry, which was likely a 
consequence of the IDT referral procedure that prioritizes worsened patient status. 
Uncontrolled studies that simply attribute the decrease in sickness absence from the 
first visit to the clinic to an intervention are therefore prone to overestimating 
treatment effects.  
 
 A data-driven model was developed that predicted at 80% accuracy whether patients 
would have low or high sickness absence in the coming two years. This suggests that 
it may be possible to identify patients that will have high sickness absence in the 
future already at baseline. Predictors of direct relevance to clinical practice included 
sick leave in the two preceding years, ongoing sick leave at entry into specialist 
healthcare, age, and confidence in recovery. Other predictors that were less 
informative were geographical location and a 2008-policy indicator, which 
nonetheless emphasized the importance of including spatial and temporal indicators in 
future predictive models.  
 
 Our results showed no support for interdisciplinary treatment decreasing sickness 
absence compared to other/no interventions. Sickness absence trends were similar in 
both groups, albeit with interdisciplinary treatment patients receiving more social 
insurance benefits over a five-year period than other patients. Further research is 
needed to elucidate whether the results were a consequence of our methodology or 
represented the actual treatment effect. Given the inconclusive state of evidence, it 
nonetheless brings into question whether current programs are suitable for mitigating 
sickness absence. 
 
 SF-36 and HADS are structurally and logically valid questionnaires with adequate 
precision for measuring core domains of the chronic pain experience. The former 
targets two independent traits of physical and mental health, while the latter is most 
suitable as an overall measure of emotional distress. Conversely, EQ-5D is not 
recommended as a unidimensional measure of HRQoL due to its insufficient 
precision.   
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7 FUTURE DIRECTIONS 
Holistic life course perspective on chronic pain 
We have described SA over a brief time period for chronic pain patients in specialist 
healthcare. With the diagnostic codes of ICD-11, new possibilities have presented themselves 
for identifying chronic pain in the general population, mapping their SA, and isolating its 
causes. Considering that chronic pain consequences extend to the social surrounding of the 
affected, it is also relevant to investigate concurrent and multigenerational consequences in 
their family for a more holistic view of the condition. 
 
Decision support tools in clinical practice 
Patients at risk of high future SA need to be identified earlier in the healthcare chain. Large 
socioeconomic gains will be made possible by preventing the SA increase two years before 
entry into specialist healthcare, which implicates identifying patients already in primary 
healthcare. Personalized medicine offers great advantages in other healthcare areas and 
decision support tools in clinical practice could prove valuable to optimize resource allocation 
for chronic pain patients.94,168 Our prediction model only provides a crude measure of the 
possibilities in SA predictions and there is no reason to believe that performance could not be 
improved. With the ever-increasing data volumes, organisation and quality are important 
limiting factors, which emphasize the need for proper structure and adequate feature 
engineering.  
 
Interdisciplinary treatment  
Evidence is needed for IDT as a sickness absence mitigator. Despite its theoretical appeal and 
international recognition as a chronic pain core intervention, scientific evidence of its effects 
on SA is surprisingly limited. In part, this is understandable given the combined complexity 
of chronic pain and IDT; however, it emphasizes the need for more rigorous studies. Properly 
designed and conducted randomized controlled trials remain the cornerstone of causal 
inference, which in combination with the Swedish National Registers would permit cost-
effective long-term follow-up with minimal attrition.81 These registers are also important for 
pragmatic observational trials to establish generalizability to real-world practice. If primary 
healthcare data is incorporated into the National Patient Register, as proposed by the National 
Board of Health and Welfare, several of the limitations of National Quality Registers could 
be overcome.126 Finally, it is important to discourage the practice of uncontrolled before-and-
after studies of IDT effects on SA given their severe limitations and minimal contribution to 






Consensus on chronic pain experience questionnaires 
A broader consensus on core domain questionnaires of the chronic pain experience is needed. 
Few established instruments would lay the foundation for a better understanding of the 
condition, facilitate comparison, and increase coherence of intervention evaluation. A central 
authority, such as IASP, could be tasked with issuing recommendations aiming to improve 
the likelihood of widespread implementation. Selected questionnaires need to be both 
theoretically motivated and psychometrically sound. Here, we evaluated some measurement 
properties of three previously recommended generic questionnaires, but even for these 
instruments, many properties remain to be examined in chronic pain patients, including 
content validity, retest reliability, and responsiveness to change.30  
 
Swedish Quality Register for Pain Rehabilitation  
SQRP is a valuable complement to the Swedish centrally governed registers for providing 
insight into the chronic pain experience. Unfortunately, it has several limitations that 
effectively restrict its relevance to clinical research. Given that the purpose of quality 
registers is to monitor and improve healthcare quality and equality, it is of public interest that 
these limitations are resolved.170 The following modifications are proposed for augmenting 
data quality to an acceptable level for pragmatic IDT evaluation. First, a better overview of 
SQRP patients is needed to assess how selection affects internal validity and generalizability. 
A feasible solution would be to routinely collect information on specialist clinic referral rates, 
IDT admission rates, and SQRP acceptance rates, combined with aggregate data on patient 
characteristics. Second, SQRP variables should be updated to better cover the domains of the 
chronic pain experience. Current information is mostly acceptable for pain characteristics and 
emotional distress, while physical and social domains are either inappropriately measured or 
absent at the cost of variables that are readily available in other registers. Adequate variable 
selection is complicated and is probably best determined by interdisciplinary competences 
with the purpose of the quality register in mind. Third, more detailed information on IDT 
program characteristics is needed to assure their quality and improve treatment effect 
assessment. No such data is currently stored in SQRP besides whether patients were assigned 
to an IDT program. Important details to include are program duration, intervention modules, 
involved care personnel, and patient compliance. Fourth, there is an urgent need to identify an 
appropriate control group to evaluate the IDT effect. Studies that simply attribute natural 
course to IDT are prone to overestimating treatment effects.38,51,161 Because it is both 
ethically and practically problematic to isolate valid control groups in the clinical setting, 
non-IDT SQRP patients should be further explored as a viable alternative, given their 
similarity to IDT patients in measured baseline variables. Information on clinical decision 
criteria is therefore necessary to understand the mechanism behind the selection procedure 
and how these patients may differ. In the best case, patients assigned to treatments other than 
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10.1 STATISTICAL SOFTWARE 
Table 1S. R packages 
Study 1  Study 2  Study 3 
Name Version  Name Version  Name Version 
car 3.0-3  corrplot 0.84  data.table 1.13.0 
corrplot 0.84  cowplot 1.0.0  DescTools 0.99.37 
ggplot2 3.2.0  data.table 1.13.0  flexsurv 1.1.1 
ggExtra 0.8  DescTools 0.99.37  ggplot2 3.3.2 
ggpubr 0.2.1  dplyr 1.0.2  haven 2.3.1 
gridExtra 2.2.1  ggalluvial 0.12.2  ipw 1.0-11 
lemon 0.4.3  ggplot2 3.3.2  lubridate 1.7.9 
lubridate 1.7.4  haven 2.3.1  msSurv 1.2-2 
mirt 1.30  Hmisc 4.4-1  mstate 0.2.12 
plyr 1.8.4  IRanges 2.22.2  rstpm2 1.5.1 
scales 1.0.0  lubridate 1.7.9  scales 1.1.1 
   psych 2.0.7  stringr 1.4.0 
   stringr 1.4.0  survival 3.1-12 
   tidyverse 1.3.0  tidyverse 1.3.0 
   TraMineR 2.2-0.1  TraMineR 2.2-0.1 
   WeightedCluster 1.4-1    
R version 3.5.2 was used in study 1, while R version 4.0.2 was used in studies 2 and 3. 
 
















Python version 3.8.3. 
  
